Joseph Broderick, Md

This large, late-stage trial is testing if a medication that helps blood clot, called rFVIIa, can improve recovery for people who have a stroke caused by bleeding in the brain. The key is giving the drug within two hours of the stroke starting, with the goal of stopping the bleed…